CONSENSUS B Tat-21 is a consensus fragment providing insight into conserved residues essential for Tat regulatory function. Its sequence supports studies on ligand accessibility and cofactor recruitment. Researchers employ it to probe structural determinants of transcriptional modulation. The peptide contributes to mapping of Tat-associated binding signatures.
CAT No: H09360
1. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
3. High fat diet and GLP-1 drugs induce pancreatic injury in mice
5. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More